InfuSystem Holdings, Inc.

AMEX:INFU

Medical - Instruments & Supplies

Healthcare
$14.67 +4.00%

+$0.35 today

Market cap
$293.89M
Beta
1.42
P/E (TTM)
23.2
EPS (TTM)
$0.39
52W Low $5.38High $11.04

Volume 0.16M

Average 0.16M

INFU Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

InfuSystem Holdings, Inc.AMEX: INFU

Net Margin · Q1 FY2026 · quarter ended Mar 2026

Net margin widens to 3.0%

Net margin was 3.0% in Q1 FY2026, up 3.8 pp from a year earlier. On a trailing-twelve-month basis it was 5.6%, up 3.2 pp year over year. Over 3 fiscal years it widened by 4.6 pp.

Context

  • Net margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether net margin reaches the consensus estimate from 2 analysts of 7.1% for the fiscal year ending Dec 2026, up from 4.6% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
3.0%-2.6 pp QoQ
Last fiscal yearDec 2025
4.6%+2.9 pp YoY
LTMMar 2026
5.6%+3.2 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+3.8 pp-1.1 pp-4.9 pp
1 year+2.9 pp+2.5 pp-0.4 pp
3 years+4.6 pp+4.0 pp-0.6 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
4.6%
Year-over-year change
+2.9pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How INFU compares with its peers on the latest reported figures

  • INFU's LTM Mar 2026 net margin of 5.6% is the highest of the 3 companies compared; the peer median is -1.9%.
  • Its year-over-year change of +3.2 pp is the 2nd highest of 3, against a peer median of +6.4 pp.
  • Over three fiscal years its change of +4.6 pp compares with a peer median of +14.0 pp.
INFU Competitors Peer median
Net Margin for INFU and competitors
Company Period LTM level YoY 3-year change
INFUInfuSystem Holdings, Inc.LTM Mar 20265.6% +3.2 pp+4.6 pp
ICUIICU Medical, Inc.LTM Jun 20261.4% +3.0 pp+3.3 pp
KRMDKORU Medical Systems, Inc.LTM Mar 2026-5.3% +9.8 pp+24.6 pp
Peer median (excluding INFU) -1.9%+6.4 pp+14.0 pp

Competitors are the stored peer set for INFU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue102.38M109.91M125.79M134.86M143.44M
Cost of Revenue43.85M49.35M62.68M64.46M63.14M
Gross Profit58.54M60.56M63.11M70.4M80.3M
Gross Margin57.2%55.1%50.2%52.2%56.0%
Research & Development00000
Selling, General & Admin51.45M56.41M58.03M62.52M67.46M
Operating Expenses55.72M58.91M59.02M63.51M68.38M
Depreciation & Amortization14.63M13.36M12.51M12.5M13.29M
EBITDA17.26M14.89M16.53M20.03M25.22M
EBITDA Margin16.9%13.5%13.1%14.9%17.6%
Operating Income2.82M1.65M4.09M6.89M11.92M
Operating Margin2.8%1.5%3.2%5.1%8.3%
Interest Income00000
Interest Expense1.38M1.4M2.17M1.78M1.3M
Other Income / Expenses(1.56M)(1.52M)(2.24M)(1.83M)(1.3M)
Income Before Tax1.26M130K1.85M5.06M10.62M
Pre-Tax Margin1.2%0.1%1.5%3.8%7.4%
Income Tax Expense(163K)112K979K2.71M4M
Net Income1.42M18K872K2.35M6.63M
Net Margin1.4%0.0%0.7%1.7%4.6%
EPS (Basic)0.070.000.040.110.32
EPS (Diluted)0.060.000.040.110.31
Weighted Avg Shares20.52M20.65M21.02M21.27M20.66M
Weighted Avg Shares (Diluted)22.05M21.55M21.65M21.71M21.1M

InfuSystem Holdings, Inc.

AMEX:INFU

Intrinsic Alpha fair value

Locked

Current Price

$14.67

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.